Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial

Affiliations

• ¹ Department of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. [email protected].
• ² Department of Orthopaedics/Rheumatology/Hand Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ³ Hokkaido Spinal Cord Injury Center, Bibai, Japan.
• ⁴ Department of Neurosurgery, Sendai Medical Center, Sendai, Japan.
• ⁵ Division of Neurosurgery, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
• ⁶ Department of Orthopedic Surgery, Dokkyo Medical University, Mibu, Japan.
• ⁷ Department of Orthopedic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
• ⁸ Orthopedic Surgery, Wakayama Medical University, Wakayama, Japan.
• ⁹ Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
• ¹⁰ Department of Orthopedic Surgery, Yamaguchi University School of Medicine, Yamaguchi, Japan.
• ¹¹ Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
• ¹² Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
• ¹³ Department of Orthopedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
• ¹⁴ Department of Orthopedic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.